13G Filing: Armistice Capital and Eyegate Pharmaceuticals Inc (EYEG)

Page 10 of 10

Page 10 of 10 – SEC Filing

Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13G dated June 19, 2017 relating to the Common Stock, $0.01 par value per share, of Eyegate Pharmaceuticals, Inc. shall be filed on behalf of the undersigned.
Armistice Capital, LLC
By:  /s/ Steven Boyd                     
Steven Boyd
Managing Member
Armistice Capital Master Fund Ltd.
By:  /s/ Steven Boyd                     
Steven Boyd
Director
/s/  Steven Boyd                          
Steven Boyd

Follow Kiora Pharmaceuticals Inc (NASDAQ:KPRX)

Page 10 of 10